Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

CareDx stock price, quote, forecast and news

CDNA
US14167L1035
A118WG

Price

31.54
Today +/-
+0.52
Today %
+1.86 %
P

CareDx stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the CareDx stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the CareDx stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the CareDx stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze CareDx's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

CareDx Stock Price History

DateCareDx Price
8/23/202431.54 undefined
8/22/202430.96 undefined
8/21/202433.36 undefined
8/20/202432.45 undefined
8/19/202433.99 undefined
8/16/202433.00 undefined
8/15/202428.35 undefined
8/14/202428.12 undefined
8/13/202427.61 undefined
8/12/202426.90 undefined
8/9/202427.03 undefined
8/8/202427.39 undefined
8/7/202424.28 undefined
8/6/202425.01 undefined
8/5/202423.69 undefined
8/2/202422.88 undefined
8/1/202423.58 undefined
7/31/202419.99 undefined
7/30/202418.76 undefined
7/29/202418.72 undefined
7/26/202419.01 undefined

CareDx Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into CareDx, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by CareDx from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects CareDx’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of CareDx. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into CareDx’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing CareDx’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on CareDx’s growth potential.

CareDx Revenue, EBIT and net profit per share

DateCareDx RevenueCareDx EBITCareDx Net Income
2026e399.14 M undefined714,000 undefined38.51 M undefined
2025e355.04 M undefined-33.8 M undefined18.15 M undefined
2024e331.8 M undefined-44.04 M undefined12.75 M undefined
2023280.32 M undefined-104.04 M undefined-190.28 M undefined
2022321.8 M undefined-77.2 M undefined-76.6 M undefined
2021296.4 M undefined-29.7 M undefined-30.7 M undefined
2020192.2 M undefined-22.5 M undefined-18.7 M undefined
2019127.1 M undefined-24.5 M undefined-22 M undefined
201876.6 M undefined-15.6 M undefined-46.8 M undefined
201748.3 M undefined-18.3 M undefined-55.5 M undefined
201640.6 M undefined-24.3 M undefined-39.5 M undefined
201528.1 M undefined-11.9 M undefined-13.7 M undefined
201427.3 M undefined1.3 M undefined800,000 undefined
201322.1 M undefined-900,000 undefined-3.5 M undefined
201220.5 M undefined-2.3 M undefined-5.1 M undefined
20062.9 M undefined-20.2 M undefined-19.9 M undefined
2005300,000 undefined-16.3 M undefined-16.6 M undefined
20040 undefined-13 M undefined-13 M undefined
20030 undefined-7.5 M undefined-7.5 M undefined
20020 undefined-2.9 M undefined-3.6 M undefined

CareDx Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (k)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
200220032004200520062012201320142015201620172018201920202021202220232024e2025e2026e
0000220222728404876127192296321280331355399
-----900.0010.0022.733.7042.8620.0058.3367.1151.1854.178.45-12.7718.217.2512.39
-----60.0059.0966.6760.7147.5056.2556.5863.7867.1967.2365.1163.57---
000-101213181719274381129199209178000
-2,000-7,000-13,000-16,000-20,000-2,00001,000-11,000-24,000-18,000-15,000-24,000-22,000-29,000-77,000-104,000-44,000-33,0000
-----1,000.00-10.00-3.70-39.29-60.00-37.50-19.74-18.90-11.46-9.80-23.99-37.14-13.29-9.30-
-3-7-13-16-19-5-30-13-39-55-46-22-18-30-76-190121838
-133.3385.7123.0818.75-73.68-40.00--200.0041.03-16.36-52.17-18.1866.67153.33150.00-106.3250.00111.11
27.827.827.827.827.8119.311.916.523.335.642.246.552.253.353.76000
--------------------
Details

Keystats

ⓘ

Revenue and Growth

The CareDx Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the CareDx is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
20052006201220132014201520162017201820192020202120222023
24.815.95.85.136.429.917.316.964.638.2224.7348.5293.1235.42
00.412.32.72.42.839.824.134.659.866.351.06
00000000000000
0.40.30.60.50.70.85.55.54.961017.219.219.47
0.20.30.20.30.51.31.21.41.83.63.87.99.27.76
25.416.97.68.240.334.426.826.881.171.9273.1433.4387.8313.71
1.15.62.11.622.42.92.14.19.225.94070.265.14
00000000000000
00000000000000
00006.76.733.133.133.345.544.450.243.145.7
0000121213.8121223.923.93737.540.34
0.30.50.20.10.20.20.29.60.21.31.364.41.94
1.46.12.31.720.921.35056.849.679.995.5133.2155.2153.11
26.8239.99.961.255.776.883.6130.7151.8368.6566.6543466.83
68.468.4135.2135.200000000.10.10.05
0.61.19.49.5200.7202.6235.7264.2412438632.3853.7898.8946.51
-46.7-66.5-156.6-160.2-159.4-173.1-212.6-268-311.8-333.8-352.5-383.2-460.4-678.27
000000-3.7-2.3-4.3-5.2-2.1-4.7-7.5-6.96
00000000000000
22.33-12-15.541.329.519.4-6.195.999277.7465.9431261.33
0.720.60.61.11.63.13.44.75.59.713.39.912.87
1.21.72.91.82.55.59.48.711.218.825.643.840.635.43
0.30.21.30.71.40.15.5153.410.533.920.225.429.77
00000000000000
0.241.54.562.922.815.70.200.1000
2.47.96.37.61110.140.842.819.534.869.377.375.978.07
0.16.213.411.45.512.91.118.3000000
0000006.14.9321.30.400.14
2.1626.33.33.1923.312.315.920.32336.1127.29
2.212.215.417.78.81616.246.515.317.921.623.436.1127.43
4.620.121.725.319.826.15789.334.852.790.9100.7112205.5
26.923.19.79.861.155.676.483.2130.7151.7368.6566.6543466.83
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of CareDx provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand CareDx's financial health and stability.

Assets

CareDx's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that CareDx must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of CareDx after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into CareDx's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (k)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
200420052006201220132014201520162017201820192020202120222023
-13-16-19-5-30-13-39-55-46-21-18-30-76-190
00010002345781114
0000000-1-2-1-1-1-100
00111-31200-918-39-14106
0000102204046465179100100
000111103100000
000001,000000000000
-12-14-17-10-3-9-16-14-4-233-19-25-18
00-1000-100-7-3-10-20-24-9
00-900-1-1-21-6-7-22-10047-22840
00-70000-20-50-19-9067-20449
000000000000000
21101004169-1400000
21250203908196541672034-25
232610403542429500163185-4-29
------3.00-----4.00-4.00-18.00-8.00-3.00
000000000000000
1011-163031-6-12938-2696213-258-7
-13.14-15.27-19.29-1.92-0.65-4.08-10.95-17.07-14.5-11.25-6.1223.07-39.55-49.57-27.63
000000000000000

CareDx stock margins

The CareDx margin analysis displays the gross margin, EBIT margin, as well as the profit margin of CareDx. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for CareDx.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the CareDx's sales revenue. A higher gross margin percentage indicates that the CareDx retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the CareDx's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the CareDx's total revenue generated. When comparing the revenue margin year over year, investors can gauge the CareDx's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the CareDx. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the CareDx's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

CareDx Margin History

CareDx Gross marginCareDx Profit marginCareDx EBIT marginCareDx Profit margin
2026e63.61 %0.18 %9.65 %
2025e63.61 %-9.52 %5.11 %
2024e63.61 %-13.27 %3.84 %
202363.61 %-37.12 %-67.88 %
202265.13 %-23.99 %-23.8 %
202167.14 %-10.02 %-10.36 %
202067.17 %-11.71 %-9.73 %
201964.2 %-19.28 %-17.31 %
201856.92 %-20.37 %-61.1 %
201755.9 %-37.89 %-114.91 %
201648.03 %-59.85 %-97.29 %
201563.7 %-42.35 %-48.75 %
201468.86 %4.76 %2.93 %
201358.82 %-4.07 %-15.84 %
201260.98 %-11.22 %-24.88 %
20066.9 %-696.55 %-686.21 %
2005-433.33 %-5,433.33 %-5,533.33 %
200463.61 %0 %0 %
200363.61 %0 %0 %
200263.61 %0 %0 %

CareDx Stock Sales Revenue, EBIT, Earnings per Share

The CareDx earnings per share therefore indicates how much revenue CareDx has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue CareDx earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates CareDx's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of CareDx’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating CareDx's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

CareDx Revenue, EBIT and net profit per share

DateCareDx Sales per ShareCareDx EBIT per shareCareDx Earnings per Share
2026e7.66 undefined0 undefined0.74 undefined
2025e6.82 undefined0 undefined0.35 undefined
2024e6.37 undefined0 undefined0.24 undefined
20235.21 undefined-1.94 undefined-3.54 undefined
20226.04 undefined-1.45 undefined-1.44 undefined
20215.68 undefined-0.57 undefined-0.59 undefined
20204.13 undefined-0.48 undefined-0.4 undefined
20193.01 undefined-0.58 undefined-0.52 undefined
20182.15 undefined-0.44 undefined-1.31 undefined
20172.07 undefined-0.79 undefined-2.38 undefined
20162.46 undefined-1.47 undefined-2.39 undefined
20152.36 undefined-1 undefined-1.15 undefined
20142.94 undefined0.14 undefined0.09 undefined
201322.1 undefined-0.9 undefined-3.5 undefined
201220.5 undefined-2.3 undefined-5.1 undefined
20060.1 undefined-0.73 undefined-0.72 undefined
20050.01 undefined-0.59 undefined-0.6 undefined
20040 undefined-0.47 undefined-0.47 undefined
20030 undefined-0.27 undefined-0.27 undefined
20020 undefined-0.1 undefined-0.13 undefined

CareDx business model

CareDx Inc is a US-based company specializing in diagnostic solutions for the transplantation industry. The company was founded in 1998 and is at the forefront of developing tests for transplant patients. CareDx is one of the most popular companies on Eulerpool.com.

CareDx SWOT Analysis

Strengths

CareDx Inc is a leader in the field of transplant diagnostics, providing innovative solutions for organ transplant patients and healthcare professionals. The company has established a strong reputation for its high-quality products and services.

CareDx Inc has a diverse and experienced team of professionals who possess deep knowledge and expertise in transplant medicine, molecular diagnostics, and bioinformatics. This allows the company to develop advanced diagnostic tools and technologies that meet the specific needs of transplant patients.

The company's product portfolio includes a range of diagnostic tests that help assess the risk of rejection in organ transplant recipients, monitor post-transplant health, and guide personalized treatment decisions. These tests have the potential to improve patient outcomes and reduce healthcare costs.

CareDx Inc has established strong relationships with transplant centers, hospitals, and clinics worldwide, providing them with reliable diagnostic solutions and support. This widespread adoption of the company's products contributes to its continued growth and market leadership.

Weaknesses

As a specialized company focused on transplant diagnostics, CareDx Inc may be vulnerable to changes in regulations or reimbursement policies that affect the transplant industry. These regulatory uncertainties can impact the demand and usage of the company's products.

The company's reliance on a limited number of key customers, such as transplant centers, may pose a risk to its business. Any significant loss of these key customers could have a negative impact on CareDx Inc's revenue and market share.

CareDx Inc's heavy investment in research and development (R&D) to develop innovative products and technologies may result in increased expenses and financial risks. The success and commercialization of these R&D efforts are not guaranteed, and any setbacks could adversely affect the company's financial performance.

Opportunities

The increasing demand for transplant procedures, driven by the growing prevalence of organ failure and advancements in transplantation techniques, presents opportunities for CareDx Inc to expand its customer base and revenue. The company can capitalize on this trend by enhancing its diagnostic capabilities and continuously developing new solutions.

Expanding into emerging markets, where transplant diagnostics may be underdeveloped, can be a strategic opportunity for CareDx Inc. By establishing partnerships or alliances with local healthcare providers, the company can introduce its products and services to a wider audience and gain a competitive edge.

The advancements in genomics and personalized medicine offer the potential for CareDx Inc to further tailor its diagnostic tools and provide personalized transplant solutions. By leveraging these technologies, the company can enhance patient care and differentiate itself from competitors.

Threats

Competition from other companies operating in the transplant diagnostics market poses a threat to CareDx Inc's market share. These competitors may offer similar products or develop alternative diagnostic technologies that could disrupt the market and capture a portion of CareDx Inc's customer base.

Changes in healthcare policies and insurance coverage can impact the demand for CareDx Inc's products. Reduced reimbursement rates or limitations in coverage for transplant diagnostics could affect the company's ability to generate revenue and maintain profitability.

The unpredictable nature of organ availability and the success of transplant procedures can also pose a threat to CareDx Inc. If the number of transplant procedures declines or if organ rejection rates decrease significantly, the demand for the company's diagnostic tests may be affected.

CareDx Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

CareDx historical P/E ratio, EBIT, and P/S ratio.

CareDx shares outstanding

The number of shares was CareDx in 2023 — This indicates how many shares 53.765 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue CareDx earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates CareDx's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of CareDx’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating CareDx's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for CareDx.

CareDx latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/2024-0.15 0.25  (270.18 %)2024 Q2
3/31/2024-0.21 -0.03  (85.72 %)2024 Q1
12/31/2023-0.27 -0.17  (37.43 %)2023 Q4
9/30/2023-0.4 -0.18  (55.37 %)2023 Q3
6/30/2023-0.32 -0.18  (43.07 %)2023 Q2
3/31/2023-0.11 -0.11  (0.18 %)2023 Q1
12/31/2022-0.09 -0.07  (20.36 %)2022 Q4
9/30/2022-0.14 -0.06  (57.98 %)2022 Q3
6/30/2022-0.11 -0.13  (-13.84 %)2022 Q2
3/31/2022-0.05 -0.13  (-154.9 %)2022 Q1
1
2
3
4
...
5

Eulerpool ESG Scorecard© for the CareDx stock

Eulerpool World ESG Rating (EESG©)

43/ 100

🌱 Environment

25

👫 Social

68

🏛️ Governance

37

Environment

Scope 1 - Direct Emissions
1,080.02
Scope 2 - Indirect emissions from purchased energy
—
Scope 3 - Indirect emissions within the value chain
—
Total CO₂ emissions
1,080.02
CO₂ reduction strategy
✅
Coal energy
❌
Nuclear power
❌
Animal experiments
❌
Fur & Leather
—
Pesticides
—
Palm Oil
—
Tobacco
❌
Genetically modified organisms
❌
Climate concept
—
Sustainable forestry
—
Recycling regulations
❌
Environmentally friendly packaging
❌
Hazardous substances
❌
Fuel consumption and efficiency
❌
Water consumption and efficiency
✅

Social

Percentage of female employees58.3
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content❌
Alcohol❌
Weapons—
Firearms
❌
Gambling❌
Military contracts❌
Human rights concept❌
Privacy concept—
Occupational health and safety✅
Catholic✅

Governance (Corporate Governance)

Environmental reporting✅
Stakeholder Engagement✅
Call Back Policies❌
Antitrust law❌

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

CareDx list of shareholders

%
Name
Stocks
Change
Date
8.56 % BlackRock Institutional Trust Company, N.A.4,456,321223,91912/31/2023
7.91 % The Vanguard Group, Inc.4,119,682-10,36212/31/2023
7.59 % Bellevue Asset Management AG3,954,79213,99412/31/2023
5.37 % State Street Global Advisors (US)2,796,267-912,88112/31/2023
5.28 % Nikko Asset Management Co., Ltd.2,748,338-126,5613/31/2024
4.23 % D. E. Shaw & Co., L.P.2,201,221-123,21112/31/2023
4.02 % Gagnon Securities LLC2,096,04420,90012/31/2023
2.62 % Renaissance Technologies LLC1,362,100315,80012/31/2023
2.23 % Geode Capital Management, L.L.C.1,158,95650,14112/31/2023
2.17 % First Eagle Investment Management, L.L.C.1,131,207126,01812/31/2023
1
2
3
4
5
...
10

CareDx Executives and Management Board

Mr. Alexander Johnson49
CareDx Chief Executive Officer
Compensation 5.72 M
Mr. Abhishek Jain47
CareDx Chief Financial Officer
Compensation 2.34 M
Mr. Michael Goldberg65
CareDx Independent Chairman of the Board (since 2011)
Compensation 404,922
Mr. George Bickerstaff67
CareDx Independent Director
Compensation 331,371
Dr. Grace Colon56
CareDx Independent Director
Compensation 325,862
1
2
3

Most common questions regarding CareDx

What values and corporate philosophy does CareDx represent?

CareDx Inc represents values of innovation, patient-centricity, and excellence in personalized medicine. The company is committed to transforming patient care through transplant diagnostics and novel digital health solutions. CareDx emphasizes collaboration with clinicians and industry partners to deliver breakthrough technologies that improve outcomes for transplant patients. With a focus on providing accurate, timely, and actionable information, CareDx strives to empower healthcare professionals with the tools needed to make informed decisions and improve patient lives. By leveraging their expertise in genomics and diagnostic testing, CareDx is driving advancements in the field of transplantation and leading the way in improving the standard of care.

In which countries and regions is CareDx primarily present?

CareDx Inc is primarily present in the United States, with its headquarters located in Brisbane, California. As a leading precision medicine company, CareDx focuses on improving patient outcomes through advancing diagnostic solutions for transplant patients. With a wide range of innovative products and services, CareDx aims to optimize transplant management and enhance long-term patient care. While CareDx operates globally, its primary presence remains concentrated within the United States.

What significant milestones has the company CareDx achieved?

CareDx Inc has achieved several significant milestones since its inception. The company has made notable advancements in the field of transplant diagnostics. It has successfully developed and commercialized innovative testing solutions, such as AlloSure and AlloMap, which help healthcare professionals monitor organ transplant recipient's immune system. CareDx Inc has also expanded its portfolio with the acquisition of other diagnostic technologies, allowing it to offer a comprehensive range of solutions. Additionally, the company has collaborated with renowned transplant centers and research institutions, further enhancing its expertise and reputation in the field. These accomplishments demonstrate CareDx Inc's commitment to improving transplant patient outcomes through cutting-edge diagnostics.

What is the history and background of the company CareDx?

CareDx Inc is a leading precision medicine company focused on transforming patient care through diagnostic solutions. Established in 1998, CareDx specializes in transplant diagnostics, offering a comprehensive suite of products and services to assess the health of transplanted organs. The company's innovative technologies, such as AlloSure and AlloMap, enable healthcare providers to monitor transplant patients and personalize treatment plans. With a strong commitment to improving outcomes for transplant recipients, CareDx has played a significant role in advancing transplant medicine. CareDx Inc continues to be a trusted name in the healthcare industry, providing valuable insights and solutions for clinicians and patients alike.

Who are the main competitors of CareDx in the market?

The main competitors of CareDx Inc in the market include companies such as Natera Inc, Illumina Inc, and Thermo Fisher Scientific Inc.

In which industries is CareDx primarily active?

CareDx Inc is primarily active in the biotechnology and healthcare industries.

What is the business model of CareDx?

The business model of CareDx Inc. revolves around providing personalized medicine solutions for transplant patients. CareDx utilizes advanced diagnostic tools and technology to improve the outcome of organ transplant procedures. The company specializes in developing and delivering innovative molecular diagnostic solutions, including its flagship product, AlloSure, which helps assess the health and function of transplanted organs. CareDx Inc. also offers a comprehensive portfolio of transplant surveillance products and services to aid physicians in managing patients post-transplant. With a focus on organ transplant patients, CareDx aims to enhance patient care and optimize transplant outcomes through its cutting-edge molecular diagnostic solutions.

What is the P/E ratio of CareDx 2024?

The CareDx P/E ratio is 133.01.

What is the P/S ratio of CareDx 2024?

The CareDx P/S ratio is 5.11.

What is the AlleAktien quality score of CareDx?

The AlleAktien quality score for CareDx is 5/10.

What is the revenue of CareDx 2024?

The expected CareDx revenue is 331.8 M USD.

How high is the profit of CareDx 2024?

The expected CareDx profit is 12.75 M USD.

What is the business model of CareDx

CareDx Inc. is a leading company in the field of diagnostic medicine and offers a wide range of products and services for transplant patients. The company is headquartered in Brisbane, California and specializes in the development, manufacturing, and marketing of solutions for monitoring and treating transplant patients. CareDx Inc. is divided into various divisions, each offering different products and services. Here are some of the main divisions of the company: Transplant Diagnostics: This division of CareDx Inc. offers a variety of tests for monitoring transplant patients. These include diagnostic tests for identifying donor and recipient characteristics, blood tests for monitoring immunosuppression, and molecular tests for determining rejection rates. These tests help doctors monitor the status of the transplant and treat it specifically. Transplant Patient Monitoring: This division of CareDx Inc. offers monitoring systems for transplant patients. These systems allow doctors to continuously monitor the patient's condition and detect early signs of rejection or other complications. The systems include devices for measuring weight, blood pressure, pulse, and other vital parameters. Transplant Care: This division of CareDx Inc. offers a wide range of services for transplant patients. These include personal care, patient and caregiver education, and support for accessing treatment services. The goal of these services is to provide comprehensive support to patients and help them achieve optimal outcomes after transplantation. Transplant Business: This division of CareDx Inc. offers specialized products and services for transplant centers and hospitals. These include training for medical staff, consulting services for best practices in transplant medicine, and specialized software for monitoring transplant patients. CareDx Inc. offers a wide range of products and services for transplant patients, all aimed at improving patient outcomes and quality of life. The company has a strong research and development department that continuously strives to develop innovative products and technologies to improve transplant medicine. The company works closely with transplant centers and medical professionals to ensure that patients' needs are met and that they receive optimal care. SEO Optimization: CareDx Inc. is a leading company in the field of diagnostic medicine and offers a wide range of products and services for transplant patients. The company is divided into various divisions, each offering different products and services. CareDx Inc. has a strong research and development department that continuously strives to develop innovative products and technologies. The company works closely with transplant centers and medical professionals to ensure that patients' needs are met. If you are looking for high-quality products and services for transplant patients, then CareDx Inc. is your best choice.

What is the CareDx dividend?

CareDx pays a dividend of 0 USD distributed over payouts per year.

How often does CareDx pay dividends?

The dividend cannot currently be calculated for CareDx or the company does not pay out a dividend.

What is the CareDx ISIN?

The ISIN of CareDx is US14167L1035.

What is the CareDx WKN?

The WKN of CareDx is A118WG.

What is the CareDx ticker?

The ticker of CareDx is CDNA.

How much dividend does CareDx pay?

Over the past 12 months, CareDx paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, CareDx is expected to pay a dividend of 0 USD.

What is the dividend yield of CareDx?

The current dividend yield of CareDx is .

When does CareDx pay dividends?

CareDx pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of CareDx?

CareDx paid dividends every year for the past 0 years.

What is the dividend of CareDx?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is CareDx located?

CareDx is assigned to the 'Health' sector.

Wann musste ich die Aktien von CareDx kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of CareDx from 8/24/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/24/2024.

When did CareDx pay the last dividend?

The last dividend was paid out on 8/24/2024.

What was the dividend of CareDx in the year 2023?

In the year 2023, CareDx distributed 0 USD as dividends.

In which currency does CareDx pay out the dividend?

The dividends of CareDx are distributed in USD.

All fundamentals about CareDx

Our stock analysis for CareDx Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CareDx Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.